Lantheus Holdings Inc (LNTH)
65.23
+0.85
(+1.32%)
USD |
NASDAQ |
Apr 24, 16:00
65.23
0.00 (0.00%)
After-Hours: 19:21
Lantheus Holdings Total Liabilities (Quarterly): 835.26M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 835.26M |
September 30, 2023 | 822.85M |
June 30, 2023 | 785.08M |
March 31, 2023 | 903.77M |
December 31, 2022 | 874.11M |
September 30, 2022 | 457.89M |
June 30, 2022 | 446.49M |
March 31, 2022 | 417.32M |
December 31, 2021 | 399.34M |
September 30, 2021 | 348.47M |
June 30, 2021 | 349.66M |
March 31, 2021 | 315.33M |
December 31, 2020 | 355.62M |
September 30, 2020 | 366.02M |
June 30, 2020 | 364.11M |
March 31, 2020 | 285.73M |
December 31, 2019 | 291.32M |
September 30, 2019 | 301.24M |
June 30, 2019 | 298.00M |
March 31, 2019 | 360.70M |
December 31, 2018 | 368.83M |
Date | Value |
---|---|
September 30, 2018 | 369.31M |
June 30, 2018 | 357.27M |
March 31, 2018 | 358.92M |
December 31, 2017 | 360.57M |
September 30, 2017 | 358.94M |
June 30, 2017 | 355.06M |
March 31, 2017 | 350.72M |
December 31, 2016 | 362.41M |
September 30, 2016 | 376.12M |
June 30, 2016 | 425.64M |
March 31, 2016 | 423.48M |
December 31, 2015 | 427.67M |
September 30, 2015 | 426.28M |
June 30, 2015 | 429.13M |
March 31, 2015 | 489.63M |
December 31, 2014 | 482.42M |
September 30, 2014 | 498.82M |
June 30, 2014 | 492.80M |
March 31, 2014 | 497.74M |
December 31, 2013 | 496.83M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
285.73M
Minimum
Mar 2020
903.77M
Maximum
Mar 2023
485.14M
Average
366.02M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
Perspective Therapeutics Inc | 22.71M |
Eli Lilly and Co | 53.14B |
Boston Scientific Corp | 15.61B |
NeuroMetrix Inc | 1.333M |
Stryker Corp | 21.32B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.651B |
Shareholders Equity (Quarterly) | 815.89M |
Debt to Equity Ratio | 0.6894 |
Current Ratio | 5.796 |
Net Debt Paydown Yield | -1.86% |